Attached files
| file | filename |
|---|---|
| EX-10.3 - EX-10.3 - ROCKET PHARMACEUTICALS, INC. | rckt-ex103_200.htm |
| EX-32.1 - EX-32.1 - ROCKET PHARMACEUTICALS, INC. | rckt-ex321_8.htm |
| EX-31.2 - EX-31.2 - ROCKET PHARMACEUTICALS, INC. | rckt-ex312_6.htm |
| EX-31.1 - EX-31.1 - ROCKET PHARMACEUTICALS, INC. | rckt-ex311_7.htm |
| EX-23.1 - EX-23.1 - ROCKET PHARMACEUTICALS, INC. | rckt-ex231_10.htm |
| EX-10.12 - EX-10.12 - ROCKET PHARMACEUTICALS, INC. | rckt-ex1012_198.htm |
| EX-10.10 - EX-10.10 - ROCKET PHARMACEUTICALS, INC. | rckt-ex1010_755.htm |
| EX-10.9 - EX-10.9 - ROCKET PHARMACEUTICALS, INC. | rckt-ex109_199.htm |
| EX-10.2 - EX-10.2 - ROCKET PHARMACEUTICALS, INC. | rckt-ex102_201.htm |
| 10-K - 10-K - ROCKET PHARMACEUTICALS, INC. | rckt-10k_20171231.htm |
Exhibit 21.1
Subsidiaries of Rocket Pharmaceuticals, Inc.
|
|
Subsidiary |
Jurisdiction of Incorporation |
Rocket Ownership |
|
1. |
Inotek Securities Corporation |
Massachusetts |
100% |
|
2. |
Inotek Ltd. |
Bermuda |
100% |
|
3. |
Rocket Pharmaceuticals, Ltd.(a) |
Cayman Islands |
100% |
|
|
(a) |
Effective January 4, 2018, Rome Merger Sub, a wholly owned subsidiary of Inotek Pharmaceuticals Corporation, merged into Rocket Pharmaceuticals, Ltd. |